The FDA has approved Alnylam’s gene silencing drug ... As the kidney function worsens, oxalate can build up and damage other organs including the heart, bones and eyes. The disease is also ...
The US FDA has approved a new orphan drug to treat patients with Cushing’s disease who cannot be helped through surgery. Novartis’ Signifor (pasireotide diaspartate) injection has been ...
26, when the U.S. Food and Drug Administration (FDA) approved Cobenfy for the psychiatric ... system as a possible treatment for Alzheimer’s disease, since manipulating it seemed to reduce ...
Travere Therapeutics TVTX announced that the FDA granted ... immunosuppressive drug Filspari (sparsentan) in IgA nephropathy (IgAN) indication, a rare progressive kidney disease.
The FDA says people with known liver impairment or moderate to severe kidney impairment should not use the drug. Summer Colling, a senior analyst at Citeline, says the novel muscarinic mechanism ...
Basel, September 17, 2024 – Novartis today announced that the US Food and Drug ... disease-free survival (iDFS) benefit was consistently observed across all patient subgroups 3-6. “The FDA ...
director of the Division of Psychiatry at the FDA’s Center for Drug Evaluation and Research. The active ingredients in Cobenfy are xanomeline and trospium chloride. The drug is designed to help ...
The FDA approved the drug ... approves first mpox diagnostic test for emergency use 1:04 PM UTC Healthcare & Pharmaceuticalscategory Gilead to donate remdesivir for emergency use against Marburg ...
Sept 27 (Reuters) - The U.S. Food and Drug Administration approved GE HealthCare's (GEHC.O), opens new tab diagnostic drug for use in detection of coronary artery disease, the company said on Friday.
Roughly 1 percent of Americans suffer from schizophrenia, which is one of the 15 leading causes of disability worldwide, the FDA reports ... or kidney disease. Even so, the drug offers a promising ...
(Reuters) -The U.S. Food and Drug ... Alzheimer's disease." People affected by it only live for about 13 years. The company estimates that NPC affects one in 100,000 live births. On Sept. 20, the ...
